Tenax Therapeutics is a "Sell" given its negative risk/reward skew even under bullish scenarios. Here's what investors need ...
Cartwright is a senior research fellow in law and economics at the American Institute for Economic Research. Myriad forces ...
Southwest Airlines needs to do some major damage control to "win back" the hearts of formerly loyal passengers who feel ...
For 4Q25, Nomura Natural Resources Fund Institutional Class shares outperformed its benchmark, the S&P Global Natural ...
By the time many employees see their 2026 compensation statements, they may realize something unsettling: the AI revolution ...
Introduction A disproportionate share of global neonatal deaths occurs in armed-conflict settings, where progress in reducing ...
Plus: FBI subpoenas Arizona election records, Anthropic sues Pentagon, Iranian soccer players granted asylum in Australia ...
This study explores the determinants of betting behavior in Cameroon, focusing on the socio-economic, technological, and ...
As Calgary pushes toward a population of two million, where and how people will live has become an increasingly complex ...